Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy and safety of dexmedetomidine at the time of
extubation and after extubation, in patients requiring postoperative sedation in the ICU.
Phase:
Phase 4
Details
Lead Sponsor:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer